
#4
Moscow Times
October 18, 2001
Perfect Anthrax Application
By Pavel Felgenhauer
The Soviet Union actively developed biological weapons in violation of the
1972 international convention banning them, and anthrax was one of the
favorites. Only in April 1992, after the demise of the Soviet Union, did
President Boris Yeltsin sign a decree banning work on biological weapons and
officially acknowledging that the treaty had been violated by Russia.
In unfavorable conditions, anthrax can form a spore -- a thick-walled capsule
inside the body of the bacteria -- that contains the DNA and other essential
parts of the living bug. Such spores can withstand frost, heat and drought for
decades, sometimes even centuries. When the spore finds favorable habitation, it
hatches to produce a living pathogenic bug.
Many different species of bacteria found in the soil can also form spores,
but anthrax is the only one known to be able to infect humans -- through small
skin cuts or through inhalation -- and develop into a potentially deadly
disease. This makes anthrax an ideal bioweapon: It can be mass-produced and
stockpiled in peacetime. In fact, anthrax can be loaded into military delivery
systems years before actual use.
However, anthrax's main shortcoming in a military application is that any
potential enemy will probably be prepared for it. During the Cold War, Russia
and the United States prepared millions of doses of anthrax vaccine to treat all
combatants in time of war.
Russia possesses some rare natural strains of anthrax, and the Russian
military boasts of having the world's best complex anthrax vaccine -- a compound
that supposedly protects against all existing anthrax bugs, including those that
the West does not possess. In the fall of 1990, the United States asked to buy
this vaccine for its troops in anticipation of a possible Iraqi bacteriological
attack during the Gulf War. The Soviet authorities, however, turned down the
request, mainly for security reasons according to Defense Ministry sources.
Anthrax may cause serious outbreaks in cattle, but is not easily (if ever)
transferred from human to human. Antibiotics can effectively treat anthrax if
diagnosed in time, and in most cases, it takes millions of spores to cause
sickness, since the human immune system can effectively cope with smaller-scale
infections. The effectiveness of anthrax and other bioweapons depends on the
weather conditions at the time of release and on other factors.
Other infectious bugs that may be used as bioweapons have to be kept alive
till delivery and are not as easy to stockpile as anthrax. Under the the Soviet
Medical and Microbiological Industry Ministry, a network of industrial plants
and research centers was built between 1970 and 1980 to produce commercial
single-cell protein from yeast. Military sources say that in wartime, the same
facilities could mass-produce lethal germs.
The Russian military was also very much interested in investigating the
possibilities of creating lab-designed lethal bugs with the help of genetic
engineering techniques. Special expeditions were also sent to Africa and Asia to
collect rare local contagious bacteria and viruses. The task was not only to
find new vicious bugs for military use, but also to prepare antitoxins to defend
against the United States, which was also active in the same field.
Still, the biological military effort was not part of the mainstream Soviet
military buildup. Soviet generals had in 1986 up to 50,000 nuclear warheads and
40,000 tons of chemical weapons -- much better payloads for their missiles than
anthrax. Bioweapons could kill hundreds of thousands or no one at all, depending
on the weather and other factors that are hard to predict. Four star General
Mikhail Kolesnikov, Chief of Russia's General Staff from 1992 until 1996, told
me that during Soviet times, "biological warfare was never an intrinsic
part of the Soviet military doctrine, and we did not include biological weapons
in our plans."
Today, however, the perfect application has at last been found for anthrax
and other such bugs: The inaccuracy and unpredictability of bioweapons makes
them the perfect terrorist weapon that may kill few, but is guaranteed to
terrify all.
The main consequence is that international pharmaceutical companies will
drastically increase sales and profits. Market regulators should look into
recent pharmacy stock transactions. Who was the guy that was placing huge buying
orders from Kandahar, when the markets went into free fall last month?
Pavel Felgenhauer is an independent defense analyst.
BACK TO THE TOP #176 CONTENTS NEXT SECTION
|